Platelet activation by oxidatively modified low density lipoproteins.

No abstract is available for this paper.

• Publication year

  1989

• Venue

  Atherosclerosis

• Publication date

  1989-04-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/0021-9150(89)90094-4PMID 2730708
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Platelet activation.

  2020cited by this paper
• Platelet function and platelet phospholipids in patients with hyperbetalipoproteinemia. Effect of nicotinic acid and clofibrate.

  2009cited by this paper
• Platelets and coagulation in patients with familial hypercholesterolemia (type IIa).

  2009cited by this paper
• Low density lipoprotein causes general cellular activation with increased phosphatidylinositol turnover and lipoprotein catabolism.

  1988cited by this paper
• The role of altered lipoproteins in the pathogenesis of atherosclerosis.

  1987cited by this paper
• Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit.

  1987cited by this paper
• Oxidation of human low density lipoprotein results in derivatization of lysine residues of apolipoprotein B by lipid peroxide decomposition products.

  1987cited by this paper
• Intracellular mechanisms in the activation of human platelets by low-density lipoproteins.

  1987cited by this paper
• Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis.

  1987cited by this paper
• Endogenous lipoproteins modify the thromboxane formation capacity of platelets.

  1986cited by this paper
• Platelet formation of 12-hydroxyeicosatetraenoic acid and thromboxane B2 is increased in type IIA hypercholesterolemic subjects.

  1986cited by this paper
• Thromboxane A2 (TXA2) formation by washed human platelets under the influence of low and high density lipoproteins from healthy donors.

  1986cited by this paper
• Thrombin binding and response in platelets from patients with dyslipoproteinemias: increased stimulus-response coupling in type II hyperlipoproteinemia.

  1986cited by this paper
• Platelet protein phosphorylation, elevation of cytosolic calcium, and inositol phospholipid breakdown in platelet activation induced by plasmin.

  1986cited by this paper
• Platelet function in hyperlipoproteinaemia.

  1985cited by this paper
• Plasma lipoproteins affect platelet malondialdehyde and thromboxane B2 production.

  1985cited by this paper
• Membrane lipid composition and cellular function.

  1985cited by this paper
• Prostacyclin-lipoprotein interactions. Studies on human platelet aggregation and adenylate cyclase.

  1985cited by this paper
• Monocytes and Neutrophils Oxidize Low Density Lipoprotein Making It Cytotoxic

  1985cited by this paper
• Increased platelet sensitivity and thromboxane B2 formation in type‐II hyperlipoproteinaemic patients

  1984cited by this paper
• Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids.

  1984cited by this paper
• Abnormal plasma lipoprotein composition in hypercholesterolaemic patients induces platelet activation

  1984cited by this paper
• The effect of blood constituents on platelet function: role of blood cells and plasma lipoproteins.

  1983cited by this paper
• Influence of Plasma Lipoproteins on Platelet Aggregation in a Normal Male Population

  1983cited by this paper
• Platelet interaction with high and low density lipoproteins.

  1983cited by this paper
• Lipoprotein Oxidation and Lipoprotein‐lnduced Cytotoxicity

  1983cited by this paper
• Platelet function and lipoprotein levels after plasma-exchange in patients with familial hypercholesterolaemia.

  1983cited by this paper
• The aggregation of isolated human platelets in the presence of lipoproteins and prostacyclin.

  1983cited by this paper
• Characterization of the effect of plasma lipoproteins on platelet function in vitro.

  1983cited by this paper
• The facilitating effects of adrenaline on platelet aggregation.

  1982cited by this paper
• Platelet Sensitivity to Prostacyclin and Thromboxane Production in Hyperlipidemic Patients

  1982cited by this paper
• Platelet function in familial hypercholesterolaemia in South Africa and the effects of probucol.

  1982cited by this paper
• ASSAY FOR SERUM LIPID PEROXIDE LEVEL AND ITS CLINICAL SIGNIFICANCE

  1982cited by this paper
• Platelet function and platelet lipid composition in the dyslipoproteinemias.

  1980cited by this paper
• Increased in vivo and in vitro platelet function in type II- and type IV-hyperlipoproteinemia.

  1979cited by this paper
• Membrane microenvironmental changes during activation of human blood platelets by thrombin. A study with a fluorescent probe.

  1979cited by this paper
• Microsomal lipid peroxidation.

  1978cited by this paper
• Abnormalities of cholesterol-phospholipid composition in platelets and low-density lipoproteins of human hyperbetalipoproteinemia.

  1977cited by this paper
• Platelet function in hyperlipoproteinemia.

  1974cited by this paper
• Practical methods for plasma lipoprotein analysis.

  1968cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• The immune receptor FcRγ-chain mediates CD36-induced platelet activation and thrombosis by oxidized low-density lipoproteins

  2025cites this paper
• Metabolic landscape in venous thrombosis: insights into molecular biology and therapeutic implications

  2024cites this paper
• Comparative analysis of Lox-1 and CD36 expression in human platelets and on circulating microparticles during ARDS-induced coagulopathy.

  2024cites this paper
• OxLDL sensitizes platelets for increased formation of extracellular vesicles capable of finetuning macrophage gene expression.

  2023cites this paper
• The Role of CD36/GPIV in Platelet Biology

  2023cites this paper
• Oxidised Low-Density Lipoprotein-Induced Platelet Hyperactivity—Receptors and Signalling Mechanisms

  2022cites this paper
• Relationship between lipoproteins, thrombosis, and atrial fibrillation

  2021cites this paper
• Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel

  2020cites this paper
• The Antioxidant Role of One-Carbon Metabolism on Stroke

  2020cites this paper
• Oxidized low‐density lipoprotein in inflammation‐driven thrombosis

  2018cites this paper
• Dyslipidemia-associated atherogenic oxidized lipids induce platelet hyperactivity through phospholipase Cγ2-dependent reactive oxygen species generation

  2018cites this paper
• Chapter 3 – Degenerated HDL and Its Clinical Implications

  2017cites this paper
• Mildly oxidized HDL decrease agonist-induced platelet aggregation and release of pro-coagulant platelet extracellular vesicles.

  2017cites this paper
• Atherogenic lipid stress induces platelet hyperactivity through CD36-mediated hyposensitivity to prostacyclin: the role of phosphodiesterase 3A

  2016cites this paper
• The role of scavenger receptors in oxidised low-density lipoprotein induced platelet hyperactivity

  2016cites this paper
• Lipoproteins as modulators of atherothrombosis: From endothelial function to primary and secondary coagulation.

  2016cites this paper
• Oxidative theory of atherosclerosis and antioxidants.

  2016cites this paper
• Gender-related impact on outcomes of high density lipoprotein in acute ST-elevation myocardial infarction.

  2016cites this paper
• Rôle des lipides oxydés dans la régulation de l'activation plaquettaire par les lipoprotéines de haute densité (HDL) plasmatiques et implication dans le diabète de type 2

  2015cites this paper
• Oxidized LDL activates blood platelets through CD36/NOX2-mediated inhibition of the cGMP/protein kinase G signaling cascade.

  2015cites this paper
• Pro-oxidant HDL predicts poor outcome in patients with ST-elevation acute coronary syndrome

  2015cites this paper
• Elastic modulus of low-density lipoprotein as potential indicator of its oxidation

  2015cites this paper
• Tyrosine kinase inhibitors modulate platelet function in vitro, ex vivo and in vivo

  2015cites this paper
• Effect of the Flavonol Quercetin on Human Platelet Function: A Review

  2015cites this paper
• Oxidised LDL activates blood platelets through CD36-NADPH oxidase-mediated inhibition of the cgmp/protein kinase g signalling cascade

  2015cites this paper
• pathways signaling - shape change through tyrosine kinase and Rho kinase Oxidized low-density lipoproteins induce rapid platelet activation and

  2014cites this paper
• Effects of in utero Diesel Exhaust Exposure on Development of Atherosclerosis in Hyperlipidemic Mice

  2014cites this paper
• Atherogenesis and atherosclerosis in primary antiphospholipid syndrome

  2013cites this paper
• Inhibitory effects of in vivo oxidized high‐density lipoproteins on platelet aggregation: evidence from patients with abetalipoproteinemia

  2013cites this paper
• The influence of oxidised low density lipoproteins on platelet activation

  2013cites this paper
• PLATELETS AND THROMBOPOIESIS Oxidized low-density lipoproteins induce rapid platelet activation and shape change through tyrosine kinase and Rho kinase – signaling pathways

  2013cites this paper
• Oxidized low-density lipoproteins induce rapid platelet activation and shape change through tyrosine kinase and Rho kinase-signaling pathways.

  2013cites this paper
• Oxidized low-density lipoprotein-induced CD147 expression and its inhibition by high-density lipoprotein on platelets in vitro.

  2013cites this paper
• The effect of the flavonols quercetin and 3', 4' dihydroxyflavonol on platelet function in vitro and in vivo

  2012influential citation
• Estimation of cell membrane properties and erythrocyte red-ox balance in patients with metabolic syndrome

  2012cites this paper
• Native high-density lipoproteins inhibit platelet activation via scavenger receptor BI: role of negatively charged phospholipids.

  2011cites this paper
• EFFECT OF 1% HYDROGEN PEROXIDE (H2O2) IN DRINKING WATER ON SOME PARAMETERS IN ِ ِADULT MALE RABBITS

  2010cites this paper
• The in vitro effects of niacin on platelet biomarkers in human volunteers

  2010cites this paper
• ATVB in Focus Platelets Unplugged: Focus on Platelet Biology

  2010cites this paper
• Hypochlorite-oxidized LDL induces intraplatelet ROS formation and surface exposure of CD40L--a prominent role of CD36.

  2010cites this paper
• Functional Change in the HDL Particle by Oxidative Modification and its Contribution to Atherogenesis

  2010cites this paper
• High‐density lipoproteins, platelets and the pathogenesis of atherosclerosis

  2010cites this paper
• Modification of platelet shape change parameter by modified phospholipids in oxidized LDL.

  2009cites this paper
• Ezetimibe's effect on platelet aggregation and LDL tendency to peroxidation in hypercholesterolaemia as monotherapy or in addition to simvastatin.

  2008cites this paper
• Interaction of LDL and platelets in ischaemic and ischaemic risk subjects

  2008cites this paper
• A Specific CD36-Dependent Signaling Pathway Is Required for Platelet Activation by Oxidized Low-Density Lipoprotein

  2008cites this paper
• Homocysteine Activates Platelets In Vitro

  2008cites this paper
• Platelet function under systemic oxidative stress The role of native and modified lipoproteins

  2008cites this paper
• Oxidized high‐density lipoprotein inhibits platelet activation and aggregation via scavenger receptor BI

  2008influential citation
• Comparative study between the prophylactics Effects of aqueous extract of Black Currant (Vitis vinferia.L) and vitamin E on some biological parameters related with heart diseases in oxidative Stressed rats

  2008cites this paper
• Platelet activation by collagen is increased in retinal vein occlusion

  2007cites this paper
• Maria Febbraio and aggregation via scavenger receptor BI Oxidized high-density lipoprotein inhibits platelet activation and

  2007influential citation
• Einfluss von oxLDL auf die Apoptoseinduktion und Zellkopplung über Gap Junctions

  2007cites this paper
• Platelet Activation by Oxidized Low Density Lipoprotein Is Mediated by Cd36 and Scavenger Receptor-A

  2007cites this paper
• Platelet Interaction with Bioactive Lipids Formed by Mild Oxidation of Low-Density Lipoprotein

  2006cites this paper
• Inhibitory mechanisms of low concentrations of oxidized low-density lipoprotein on platelet aggregation.

  2006cites this paper
• Modifi ed Low-Density Lipoproteins and High-Density Lipoproteins From Investigation Tools to Real in vivo Players

  2006cites this paper
• Platelet Activation by Low Density Lipoprotein and High Density Lipoprotein

  2006cites this paper
• Modified Low-Density Lipoproteins and High-Density Lipoproteins

  2006cites this paper
• Platelets and lipoproteins: how much do we know about their interactions?

  2006cites this paper
• Glycation Accelerates Lipoprotein by Copper the Oxidation of Low Densi Ions

  2006cites this paper
• Low-density lipoproteins inhibit histamine and NaNO2 relaxations of the coronary vasculature and reduce contractile function in isolated rat hearts

  2005cites this paper
• Effect of Oxidation on the Platelet-Activating Properties of Low-Density Lipoprotein

  2005cites this paper
• Low concentration of oxidized low density lipoprotein suppresses platelet reactivity in vitro: An intracellular study

  2004cites this paper
• Immunomodulation and vaccination for atherosclerosis

  2004cites this paper
• macrophage-derived chemokine ( CCL 22 ) when combined with low levels of ADP , thrombin , epinephrine or LDL oxidized by hypochlorous acid causes irreversible platelet aggregation

  2004cites this paper
• Possible involvement of oxidative stress in exercise‐mediated platelet activation

  2004cites this paper
• LDL oxidized by hypochlorous acid causes irreversible platelet aggregation when combined with low levels of ADP, thrombin, epinephrine, or macrophage-derived chemokine (CCL22).

  2004cites this paper
• Activated Platelet and Oxidized LDL Induce Endothelial Membrane Vesiculation: Clinical Significance of Endothelial Cell-Derived Microparticles in Patients With Type 2 Diabetes

  2004cites this paper
• Effet d'un hydroperoxyde lipidique et des LDL oxydées sur les enzymes impliquées dans la libération de l'acide arachidonique des phospholipides plaquettaires

  2004cites this paper
• Reducing Cardiovascular Risk with HMG CoA Reductase Inhibitors, Potential Contribution from Platelets

  2003cites this paper
• Impact of margarine enriched with plant sterols on blood lipids, platelet function, and fibrinogen level in young men.

  2003cites this paper
• Immunhistochemischer Nachweis veränderter Low-density-Lipoproteine (ox-LDL) in der Gefäßwand bei Patienten mit Arteriitis temporalis

  2003cites this paper
• [Immunohistochemical detection of altered low density lipoprotein (ox-LDL) in the vessel walls of patients with giant cell arteritis].

  2003cites this paper
• New insights in platelet signaling by Low Density Lipoprotein

  2003cites this paper
• Reduced platelet aggregation after fluvastatin therapy is associated with altered platelet lipid composition and drug binding to the platelets.

  2003cites this paper
• Atherosclerosis, Hypertension and Diabetes

  2003cites this paper
• Platelet Activation by the apoB/E Receptor-binding Domain of LDL

  2002cites this paper
• Fluorescence spectroscopic analysis of circulating platelet activation during coronary angioplasty

  2001cites this paper
• Lysophosphatidic acid‐independent platelet activation by low‐density lipoprotein

  2001cites this paper
• Characterization of simple and reproducible vascular stenosis model in hypercholesterolemic hamsters

  2001cites this paper
• Apo A-I binding to platelets detected by flow cytometry.

  2001cites this paper
• Influence of acute exercise on human platelet responsiveness: possible involvement of exercise-induced oxidative stress

  2001cites this paper
• Possible involvement of increased susceptibility of LDL to oxidation in age‐related platelet activation

  2001cites this paper
• Activation-dependent surface expression of LOX-1 in human platelets.

  2001cites this paper
• Activated platelets in patients with severe hypertriglyceridemia: effects of triglyceride-lowering therapy.

  2000cites this paper
• Oxidized Phospholipids as Mediators of Vascular Disease

  2000cites this paper
• Effects of endothelial cells and mononuclear leukocytes on platelet aggregation.

  2000cites this paper
• Modification of protein moiety of human low density lipoprotein by hypochlorite generates strong platelet agonist.

  2000cites this paper
• Hyperlipemic-very low density lipoprotein, intermediate density lipoprotein and low density lipoprotein act synergistically with serotonin on vascular smooth muscle cell proliferation.

  2000cites this paper
• Stimulating effect of biologically modified low density lipoproteins on ADP-induced aggregation of washed platelets persists in absence of specific binding.

  2000cites this paper
• Oxidized low-density lipoprotein (LDL) enhances thromboxane A(2) synthesis by platelets, but lysolecithin as a product of LDL oxidation has an inhibitory effect.

  2000cites this paper
• The effect of oxidatively modified low-density lipoproteins on platelet aggregability and membrane fluidity

  2000cites this paper
• Hypochlorite modified LDL are a stronger agonist for platelets than copper oxidized LDL

  2000cites this paper
• Molecular requirements in the recognition of low-density lipoproteins (LDL) by specific platelet membrane receptors.

  2000cites this paper
• High density lipoprotein oxidation: in vitro susceptibility and potential in vivo consequences.

  2000cites this paper
• Low-density lipoprotein activates the small GTPases Rap1 and Ral in human platelets.

  2000cites this paper
• Inhibition of platelet aggregation by putrescine, spermidine, and spermine in hypercholesterolemic rabbits.

  2000cites this paper
• Homocysteine, Coagulation, Platelet Function, and Thrombosis

  2000cites this paper
• Platelet aggregatory response to platelet activating factor (PAF), ex vivo, and PAF-acetylhydrolase activity in patients with unstable angina: effect of c7E3 Fab (abciximab) therapy.

  1999cites this paper